References
- Ali, B., Fisher, D. A., Miller, T. R., Lawrence, B. A., Spicer, R. S., Swedler, D. I., & Allison, J. (2019). Trends in drug poisoning deaths among adolescents and young adults in the United States, 2006–2015. Journal of Studies on Alcohol and Drugs, 80(2), 201–210. https://doi.org/https://doi.org/10.15288/jsad.2019.80.201
- Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376(9738), 367–387. https://doi.org/https://doi.org/10.1016/S0140-6736(10)60829-X
- Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M. M., & Mayet, S. (2008). Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. The Cochrane Database of Systematic Reviews, 0 Cd005031.
- American Foundation for AID Research. (2020). Opioid & health indicators database 2020. https://opioid.amfar.org/CT/4
- Amlani, A., McKee, G., Khamis, N., Raghukumar, G., Tsang, E., & Buxton, J. A. (2015). Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia. Harm Reduction Journal, 12(1), 54. https://doi.org/https://doi.org/10.1186/s12954-015-0088-4
- Anand, P., Springer, S. A., Copenhaver, M. M., & Altice, F. L. (2010). Neurocognitive impairment and HIV risk factors: A reciprocal relationship. AIDS and Behavior, 14(6), 1213–1226. https://doi.org/https://doi.org/10.1007/s10461-010-9684-1
- Arfken, C. L., Suchanek, J., & Greenwald, M. K. (2017). Characterizing fentanyl use in methadone-maintained clients. Journal of Substance Abuse Treatment, 75, 17–21. https://doi.org/https://doi.org/10.1016/j.jsat.2017.01.004
- Babor, T. F., McRee, B. G., Kassebaum, P. A., Grimaldi, P. L., Ahmed, K., & Bray, J. (2007). Screening, Brief Intervention, and Referral to Treatment (SBIRT): Toward a public health approach to the management of substance abuse. Substance Abuse, 28(3), 7–30. https://doi.org/https://doi.org/10.1300/J465v28n03_03
- Bagley, S. M., Schoenberger, S. F., Waye, K. M., & Walley, A. Y. (2019). A scoping review of post opioid-overdose interventions. Preventive Medicine, 128, 105813. https://doi.org/https://doi.org/10.1016/j.ypmed.2019.105813
- Bao, Y. P., Liu, Z. M., Epstein, D. H., Du, C., Shi, J., & Lu, L. (2009). A meta-analysis of retention in methadone maintenance by dose and dosing strategy. The American Journal of Drug and Alcohol Abuse, 35(1), 28–33. https://doi.org/https://doi.org/10.1080/00952990802342899
- Brooner, R. K., Kidorf, M. S., King, V. L., Peirce, J., Neufeld, K., Stoller, K., & Kolodner, K. (2013). Managing psychiatric comorbidity within versus outside of methadone treatment settings: A randomized and controlled evaluation. Addiction, 108(11), 1942–1951. https://doi.org/https://doi.org/10.1111/add.12269
- Bruijnen, C. J. W. H., Dijkstra, B. A. G., Walvoort, S. J. W., Markus, W., VanDerNagel, J. E. L., Kessels, R. P. C., & De Jong, C. A. J. (2019). Prevalence of cognitive impairment in patients with substance use disorder. Drug and Alcohol Review, 38(4), 435–442. https://doi.org/https://doi.org/10.1111/dar.12922
- Buresh, M., Genberg, B. L., Astemborski, J., Kirk, G. D., & Mehta, S. H. (2019). Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, Maryland. International Journal of Drug Policy, 74, 41–46. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.08.006
- Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Archives of Internal Medicine, 158(16), 1789–1795. https://doi.org/https://doi.org/10.1001/archinte.158.16.1789
- Carroll, J. J., Marshall, B. D. L., Rich, J. D., & Green, T. C. (2017). Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. The International Journal on Drug Policy, 46, 136–145. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.05.023
- Center for Disease Control. (2017). Prescription behavior surveillance system issue brief [cited 2020]. https://www.cdc.gov/drugoverdose/pdf/pbss/PBSS-Report-072017.pdf
- Center for Disease Control. (2020). Drug overdose deaths. https://www.cdc.gov/drugoverdose/data/statedeaths.html
- Ciccarone, D., Ondocsin, J., & Mars, S. G. (2017). Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’. The International Journal on Drug Policy, 46, 146–155. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.06.004
- Coffin, P. O., Santos, G.-M., Matheson, T., Behar, E., Rowe, C., Rubin, T., Silvis, J., & Vittinghoff, E. (2017). Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial. PLoS One, 12(10), e0183354. https://doi.org/https://doi.org/10.1371/journal.pone.0183354
- Cousins, G., Boland, F., Barry, J., Lyons, S., Keenan, E., O’Driscoll, D., Bennett, K., & Fahey, T. (2017). J-shaped relationship between supervised methadone consumption and retention in methadone maintenance treatment (MMT) in primary care: National cohort study. Drug and alcohol dependence, 173, 126–131.
- DataHaven. (2020). Towards health equity in Connecticut. https://ctdatahaven.org/reports/towards-health-equity-connecticut.
- Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R., Watters, J., Andersen, M., Williams, M., Kotranski, L., Booth, R., Rhodes, F., Weatherby, N., Estrada, A. L., Fleming, D., Deren, S., & Tortu, S. (1994). Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4), 383–392. https://doi.org/https://doi.org/10.1177/107319119400100407
- Farnum, S. O., Makarenko, I., Madden, L., Mazhnaya, A., Marcus, R., Prokhorova, T., Bojko, M. J., Rozanova, J., Dvoriak, S., Islam, Z., & Altice, F. L. (2021). The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine. Addiction (Abingdon, England), 116(1), 83–93.
- Gryczynski, J., Nichols, H., Schwartz, R. P., Mitchell, S. G., Hill, P., & Wireman, K. (2019). Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder. Drug and Alcohol Dependence, 204, 107515. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.06.017
- Hosmer, D. W., Hosmer, T., Le Cessie, S., & Lemeshow, S. (1997). A comparison of goodness-of-fit tests for the logistic regression model. Statistics in Medicine, 16(9), 965–980. https://doi.org/https://doi.org/10.1002/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O
- Kelly, T. M., & Daley, D. C. (2013). Integrated treatment of substance use and psychiatric disorders. Social Work in Public Health, 28(3-4), 388–406. https://doi.org/https://doi.org/10.1080/19371918.2013.774673
- Krieger, M. S., Yedinak, J. L., Buxton, J. A., Lysyshyn, M., Bernstein, E., Rich, J. D., Green, T. C., Hadland, S. E., & Marshall, B. D. L. (2018). High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduction Journal, 15(1), 7. https://doi.org/https://doi.org/10.1186/s12954-018-0213-2
- Macmadu, A., Carroll, J. J., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2017). Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addictive Behaviors, 68, 35–38. https://doi.org/https://doi.org/10.1016/j.addbeh.2017.01.014
- Mars, S. G., Rosenblum, D., & Ciccarone, D. (2019). Illicit fentanyls in the opioid street market: Desired or imposed?Addiction, 114(5), 774–780. https://doi.org/https://doi.org/10.1111/add.14474
- Marshall, B. D. L., Krieger, M. S., Yedinak, J. L., Ogera, P., Banerjee, P., Alexander-Scott, N. E., Rich, J. D., & Green, T. C. (2017). Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA. The International Journal on Drug Policy, 46, 130–135. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.05.029
- Morales, K. B., Park, J. N., Glick, J. L., Rouhani, S., Green, T. C., & Sherman, S. G. (2019). Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities. Drug and Alcohol Dependence, 204, 107547. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.107547
- National Institute on Drug Abuse. (2020). Connecticut: Opioid-involved deaths and related harms. https://www.drugabuse.gov/drug-topics/opioids/opioid-summaries-by-state/connecticut-opioid-involved-deaths-related-harms.
- Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA, 291(15), 1887–1896. https://doi.org/https://doi.org/10.1001/jama.291.15.1887
- Parvaresh, N., Masoudi, A., Majidi-Tabrizi, S., & Mazhari, S. (2012). The correlation between methadone dosage and comorbid psychiatric disorders in patients on methadone maintenance treatment. Addiction & Health, 4(1-2), 1–8.
- Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019). Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. The International Journal on Drug Policy, 63, 122–128. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.08.007
- Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019). Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. The International Journal on Drug Policy, 63, 122–128. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.08.007
- Peters, L., & Soyka, M. (2019). Interrelationship of opioid dependence, impaired impulse control, and depressive symptoms: An open-label cross-sectional study of patients in maintenance therapy. Neuropsychobiology, 77(2), 73–82. https://doi.org/https://doi.org/10.1159/000494697
- Preston, K. L., Umbricht, A., & Epstein, D. H. (2000). Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Archives of General Psychiatry, 57(4), 395–404. https://doi.org/https://doi.org/10.1001/archpsyc.57.4.395
- Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/https://doi.org/10.1177/014662167700100306
- Rudd, R. A., Paulozzi, L. J., Bauer, M. J., Burleson, R. W., Carlson, R. E., & Dao, D. (2014). Increases in heroin overdose deaths—28 states, 2010 to 2012. MMWR Morbidity and Mortality Weekly Report, 63(39), 849–854.
- Seth, P., Rudd, R. A., Noonan, R. K., & Haegerich, T. M. (2018). Quantifying the epidemic of prescription opioid overdose deaths. American Journal of Public Health, 108(4), 500–502. https://doi.org/https://doi.org/10.2105/AJPH.2017.304265
- Sherbourne, C. D., & Stewart, A. L. (1991). The MOS social support survey. Social Science & Medicine, 32(6), 705–714. https://doi.org/https://doi.org/10.1016/0277-9536(91)90150-B
- Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2013). Cognitive enhancement as a treatment for drug addictions. Neuropharmacology, 64(1), 452–463. https://doi.org/https://doi.org/10.1016/j.neuropharm.2012.06.021
- Spencer, M. R., Warner, M., Bastian, B. A., Trinidad, J. P., & Hedegaard, H. (2019). Drug overdose deaths involving fentanyl, 2011-2016. National vital statistics reports: From the Centers for Disease Control and Prevention, National Center for Health. Statistics, National Vital Statistics System, 68(3), 1–19.
- Stone, A. C., Carroll, J. J., Rich, J. D., & Green, T. C. (2018). Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months. Drug and Alcohol Dependence, 192, 94–97. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.07.019
- Substance Abuse and Mental Health Services Administration. (2019). In: U.S. Department of Health and Human Services (Eds.), Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health.